Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist

Regulatory Peptides

Volumn 67, Issue 2, 1996, Pages 123-130

  Krebs, Luke T ^a   Kramár, Enikö A ^a   Hanesworth, Jodie M ^a   Sardinia, Michael F ^a   Ball, Amy E ^a   Wright, John W ^a   Harding, Joseph W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Angiotensin IV; Bovine adrenal; Cerebral blood flow; Receptor binding

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; LOSARTAN POTASSIUM;

ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANGIOTENSIN II; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; CATTLE; DRUG STABILITY; FEMALE; IODINE RADIOISOTOPES; KINETICS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; SUBSTRATE SPECIFICITY;

ANIMALIA; BOVINAE;

EID: 0030568128     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00121-8     Document Type: Article

References (24)

1. [1] Bernier, S.G., Fornier, A. and Guillemette, G., A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes, Eur. J. Pharmacol., 271 (1994) 55-63.
2. [2] Braszko, J.J., Kupryszewski, G., Witczuk, B. and Wisniewski, K., Angiotensin II(3-8) hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience, 27 (1988) 777-783.
3. 1 Ang IV and Ang IV's relation to nitric oxide in the rat kidney. FASEB J., 8 (1994) A882.
4. [4] de Gasparo, M., Husain, A., Alexander, W., Catt, K.J., Chiu, A.T., Drew, M. Goodfriend, T., Harding, J.W., Inagami, T. and Timmermans, P.B., Proposed update of angiotensin receptor nomenclature, Hypertension, 25 (1995) 924-927.
5. [5] Haberl, R.L., Anneser, F., Villringer, A. and Einhäupl, K.M., Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am.J. Physiol., 258 (1990) H1840-H1846.
6. [6] Hall, K.L., Hanesworth, J.M., Ball, A.E., Felgenhauer, G.P., Hosick, H.L. and Harding, J.W., Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV, Regul. Pept., 44 (1993) 225-232.
7. [7] Hall, K.L., Venkateswaran, S., Hanesworth, J.M., Schelling, M.E. and Harding, J.W., Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells, Regul. Pept., 58 (1995) 107-115.
8. 4 receptor. FASEB J., 10 (1996) A396.
9. [9] Hanesworth, J.M., Sardinia, M.F., Krebs, L.T., Hall, K.L. and Harding, J.W., Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes, J. Pharmacol. Exp. Ther., 266 (1993) 1036-1042.
10. 4 receptors in bovine adrenal cortex, Peptides, 15 (1994) 1037-1044.
11. [11] Kerins, D.M., Hao, Q. and Vaughan, D.E., Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV, J. Clin. Invest., 96 (1995) 2515-2520.
12. 1 in the rat, Soc. Neurosci. Abstr., 21 (1995) 156.
13. [13] Marley, P.D. and Bunn, S.J., Lack of effect of opioid compounds on angiotensin II responses of bovine adrenal medullary cells, Neurosci. Lett., 90 (1988) 343-348.
14. [14] Miller-Wing, A.V., Hanesworth, J.M., Sardinia, M.F., Wright, J.W., Speth, R.C., Grove, K.L. and Harding, J.W., Central angiotensin IV receptors: distribution and specificity in guinea pig brain, J. Pharmacol. Exp. Ther., 266 (1993) 1718-1726.
15. 2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats, Regul. Pept., 52 (1994) 21-29.
16. [16] Roberts, K.A., Krebs, L.T., Kramár, E.A., Shaffer, M.J., Harding, J.W. and Wright, J.W., Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats, Brain Res., 682 (1995) 13-21.
17. [17] Rowe, B.P., Saylor, D.L. and Speth, R.C., Analysis of angiotensin II receptor subtypes in individual rat brain nuclei, Neuroendocrinology, 55 (1992) 563-573.
18. 4 receptor binding characteristics: D-amino acid-and glycine-substituted peptides, Peptides, 14 (1993) 949-954.
19. 4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues, Peptides, 15 (1994) 1399-1406.
20. [20] Swanson, G.N., Hanesworth, J.M., Sardinia, M.F., Coleman, J.K., Wright, J.W., Hall, K.L., Miller-Wing, A.V., Stobb, J.W., Cook, V.I., Harding, E.C. and Harding, J.W., Discovery of a distinct binding site for angiotensin II(3-8), a putative angiotensin for a receptor, Regul. Pept., 40 (1992) 409-419.
21. [21] Wang, L., Eberhard, M. and Erne, P., Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV, Clin. Sci., 88 (1995) 557-562.
22. [22] Wang, M.J., Baudheim, P., Courtoy, P.J. and de Potter, W., Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture, Endocrinology, 136 (1995) 5274-5282.
23. [23] Wright, J.W., Krebs, L.T., Stobb, J.W. and Harding, J.W., The Angiotensin IV system: functional implications, Front. Neuroendocrinol., 16 (1995) 23-52.
24. [24] Wright, J.W., Miller-Wing, A.V., Shaffer, M.J., Higginson, C., Wright, D.E., Hanesworth, J.M. and Harding, J.W., Angiotensin II(3-8) [ANG IV] hippocampal binding: potential role in the facilitation of memory, Brain Res. Bull., 32 (1993) 497-502.